Literature DB >> 1464358

A role for gamma scintigraphy in cancer immunology and immunotherapy.

A C Perkins1, M V Pimm.   

Abstract

Facilities for radiolabelling and gamma scintigraphy are largely restricted to nuclear medicine departments or specialised research institutions and are therefore not widely available to workers in cancer research. Despite this, there is growing interest in gamma scintigraphy, which can provide information relevant to the entire field of cancer immunology. This review discusses the present and future roles of gamma scintigraphy in respect of antibody-targeted, cell-mediated and cytokine therapy. The authors aim to show that gamma scintigraphy is an investigative tool of great potential.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464358     DOI: 10.1007/bf00180868

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  21 in total

1.  In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma.

Authors:  K D Griffith; E J Read; J A Carrasquillo; C S Carter; J C Yang; B Fisher; P Aebersold; B S Packard; M Y Yu; S A Rosenberg
Journal:  J Natl Cancer Inst       Date:  1989-11-15       Impact factor: 13.506

2.  Dosimetry and treatment planning in radioimmunotherapy.

Authors:  P K Leichner; N C Yang; B W Wessels; W G Hawkins; S E Order; J L Klein
Journal:  Front Radiat Ther Oncol       Date:  1990

3.  In vivo quantitation of lesion radioactivity using external counting methods.

Authors:  S R Thomas; H R Maxon; J G Kereiakes
Journal:  Med Phys       Date:  1976 Jul-Aug       Impact factor: 4.071

4.  A treatment planning program for radioimmunotherapy.

Authors:  D J Macey; G L DeNardo; S J DeNardo
Journal:  Front Radiat Ther Oncol       Date:  1990

5.  Quantitation in 131I-radioimmunotherapy using SPECT.

Authors:  S J Riggs; A J Green; R H Begent; K D Bagshawe
Journal:  Int J Cancer Suppl       Date:  1988

6.  Demonstration of the hepatic uptake of radiolabelled immunotoxins using gamma scintigraphy.

Authors:  A C Perkins; M V Pimm; R W Baldwin
Journal:  Eur J Cancer Clin Oncol       Date:  1987-08

7.  Imaging pattern of radiolabelled lymphokine-activated killer cells in patients with metastatic malignant melanoma.

Authors:  E Schäfer; R Dummer; C Eilles; W Börner; R Martin; J Rendl; G Burg
Journal:  Eur J Nucl Med       Date:  1991

8.  Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents.

Authors:  V S Byers; M V Pimm; I Z Pawluczyk; H M Lee; P J Scannon; R W Baldwin
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

9.  Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.

Authors:  R H Begent; J A Ledermann; A J Green; K D Bagshawe; S J Riggs; F Searle; P A Keep; T Adam; R G Dale; M G Glaser
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

10.  Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.

Authors:  C H Ford; C E Newman; J R Johnson; C S Woodhouse; T A Reeder; G F Rowland; R G Simmonds
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.